Canadians prefer to use the therapeutic properties of cannabis without intermediaries
The number of those registered with Health Canada to grow plants individually for medicinal purposes has nearly doubled since 2018. Specifically, in October 2018, 25,945 patients were allowed to grow their own medical cannabis or a person assigned to grow it on their behalf. According to the latest data, this number reached a record 43,680 in December 2020.
On the pages of the specialized electronic edition of national cannabis growers, more than once the attention of our dear readers and listeners has been focused on various areas of using the therapeutic properties of the hemp plant, which are effectively used in economically developed countries of the world. The question was raised several times that in Canada, Israel, as well as a number of other countries, the direction of using the therapeutic properties of the hemp plant is actively developing without the use of any intermediaries in the form of pharmacological companies or pharmacy chains. In the above mentioned countries, at the level of the current regulatory framework, the possibility of individual cultivation of hemp plants with enormous therapeutic potential is regulated, which leads to the rapid development of this particular segment of the hemp market. The systematized materials published by the state structures of Canada on this issue once again indicate that this market segment is extremely interested in the end patient / consumer, therefore, regulating the possibility of cultivating technical hemp with a therapeutic orientation to use the medicinal properties of the plant has an extremely powerful potential for our country as well.
According to Statistics Canada, spending by citizens of the country to use the therapeutic properties of the hemp plant through pharmacies fell to a five-year low in the first half of 2021, as a significant number of patients / consumers choose to grow their own plants.
The cost of using the therapeutic properties of cannabis in Canada
Patients / consumers in Canada spent $ 197 million (C $ 242 million - C $) on legal psychoactive cannabis in the first half of this year, up from $ 239 million (C $ 294 million) in the second half of 2020 and 23% less than the record $ 257 million (C $ 316 million) spent in the last six months of 2017. Spending in the first half of 2021 is the lowest in a six-month period since 2016, when it was $ 144 million (C $ 177 million) in the last two quarters.
Commentary of the specialists of the Association "Ukrainian technical hemp"
In Canada, most legal medical cannabis is sold directly to patients through licensed growers, but an increasing number of Canadian citizens are choosing to grow their own plants with tremendous therapeutic properties. The number of those registered with Health Canada to grow plants individually for medicinal purposes has nearly doubled since 2018. Specifically, in October 2018, 25,945 patients were allowed to grow their own medical cannabis or a person assigned to grow it on their behalf. According to the latest data, this number reached a record 43,680 in December 2020.
During the specialized round table " Exponential growth of the market for non-traditional therapeutically active elements of hemp " held as part of the training of the next course for students of the " Hemp University ", the speakers will focus on the national experience of the legal use of the medicinal properties of the leaves and inflorescences of technical hemp of therapeutic orientation, which is already actively used by citizens our country.